nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B15—prostate cancer	0.281	0.914	CbGaD
Morphine—Levorphanol—Estrone—prostate cancer	0.132	0.569	CrCrCtD
Morphine—Levorphanol—Estradiol—prostate cancer	0.0999	0.431	CrCrCtD
Morphine—CYP3A4—prostate cancer	0.0264	0.086	CbGaD
Morphine—UGT1A1—Estradiol—prostate cancer	0.02	0.0795	CbGbCtD
Morphine—UGT2B7—Epirubicin—prostate cancer	0.0194	0.0771	CbGbCtD
Morphine—CYP2C8—Nilutamide—prostate cancer	0.0171	0.0677	CbGbCtD
Morphine—CYP2C8—Abiraterone—prostate cancer	0.0141	0.0561	CbGbCtD
Morphine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0132	0.0523	CbGbCtD
Morphine—UGT1A1—Etoposide—prostate cancer	0.0131	0.0519	CbGbCtD
Morphine—CYP2D6—Bicalutamide—prostate cancer	0.0109	0.0432	CbGbCtD
Morphine—ABCB1—Estramustine—prostate cancer	0.0107	0.0426	CbGbCtD
Morphine—CYP2C8—Cabazitaxel—prostate cancer	0.0105	0.0415	CbGbCtD
Morphine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00911	0.0362	CbGbCtD
Morphine—CYP2D6—Abiraterone—prostate cancer	0.00902	0.0358	CbGbCtD
Morphine—ABCB1—Cabazitaxel—prostate cancer	0.00708	0.0281	CbGbCtD
Morphine—CYP3A4—Bicalutamide—prostate cancer	0.00692	0.0275	CbGbCtD
Morphine—ABCB1—Estrone—prostate cancer	0.00692	0.0275	CbGbCtD
Morphine—CYP3A4—Estramustine—prostate cancer	0.00644	0.0255	CbGbCtD
Morphine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00617	0.0245	CbGbCtD
Morphine—CYP2C8—Estradiol—prostate cancer	0.00587	0.0233	CbGbCtD
Morphine—CYP3A4—Abiraterone—prostate cancer	0.00574	0.0228	CbGbCtD
Morphine—CYP3A4—Flutamide—prostate cancer	0.00574	0.0228	CbGbCtD
Morphine—ABCB1—Conjugated Estrogens—prostate cancer	0.00453	0.018	CbGbCtD
Morphine—CYP3A4—Cabazitaxel—prostate cancer	0.00424	0.0168	CbGbCtD
Morphine—CYP3A4—Estrone—prostate cancer	0.00415	0.0165	CbGbCtD
Morphine—ABCB1—Mitoxantrone—prostate cancer	0.00412	0.0163	CbGbCtD
Morphine—ABCB1—Estradiol—prostate cancer	0.00398	0.0158	CbGbCtD
Morphine—CYP2C8—Etoposide—prostate cancer	0.00383	0.0152	CbGbCtD
Morphine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0037	0.0147	CbGbCtD
Morphine—ABCB1—Prednisone—prostate cancer	0.00342	0.0136	CbGbCtD
Morphine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00271	0.0108	CbGbCtD
Morphine—ABCB1—Etoposide—prostate cancer	0.0026	0.0103	CbGbCtD
Morphine—UGT1A1—urine—prostate cancer	0.00248	0.141	CbGeAlD
Morphine—CYP3A4—Mitoxantrone—prostate cancer	0.00247	0.00978	CbGbCtD
Morphine—CYP3A4—Estradiol—prostate cancer	0.00238	0.00945	CbGbCtD
Morphine—ABCB1—Docetaxel—prostate cancer	0.00237	0.00942	CbGbCtD
Morphine—CYP3A4—Prednisone—prostate cancer	0.00205	0.00813	CbGbCtD
Morphine—ABCB1—Doxorubicin—prostate cancer	0.00177	0.00702	CbGbCtD
Morphine—UGT2B15—prostate gland—prostate cancer	0.00172	0.0975	CbGeAlD
Morphine—CYP2D6—Doxorubicin—prostate cancer	0.00167	0.00662	CbGbCtD
Morphine—CYP3A4—Etoposide—prostate cancer	0.00156	0.00617	CbGbCtD
Morphine—CYP3A4—Docetaxel—prostate cancer	0.00142	0.00565	CbGbCtD
Morphine—UGT1A8—renal system—prostate cancer	0.0014	0.0793	CbGeAlD
Morphine—UGT2B15—urethra—prostate cancer	0.00115	0.0653	CbGeAlD
Morphine—CYP3A4—Doxorubicin—prostate cancer	0.00106	0.00421	CbGbCtD
Morphine—UGT2B7—prostate gland—prostate cancer	0.00105	0.0596	CbGeAlD
Morphine—OPRK1—prostate gland—prostate cancer	0.000986	0.056	CbGeAlD
Morphine—UGT1A1—prostate gland—prostate cancer	0.000892	0.0507	CbGeAlD
Morphine—OPRL1—testis—prostate cancer	0.00088	0.05	CbGeAlD
Morphine—CYP3A4—urine—prostate cancer	0.000796	0.0452	CbGeAlD
Morphine—CYP2D6—urine—prostate cancer	0.000783	0.0445	CbGeAlD
Morphine—UGT2B7—renal system—prostate cancer	0.000715	0.0406	CbGeAlD
Morphine—OPRD1—renal system—prostate cancer	0.000701	0.0398	CbGeAlD
Morphine—OPRL1—lymph node—prostate cancer	0.000638	0.0362	CbGeAlD
Morphine—UGT1A1—renal system—prostate cancer	0.000608	0.0345	CbGeAlD
Morphine—UGT2B7—testis—prostate cancer	0.000462	0.0263	CbGeAlD
Morphine—Naloxone—TLR4—prostate cancer	0.000428	0.257	CrCbGaD
Morphine—OPRM1—testis—prostate cancer	0.000309	0.0176	CbGeAlD
Morphine—CYP2C8—renal system—prostate cancer	0.000288	0.0163	CbGeAlD
Morphine—Galantamine—ACHE—prostate cancer	0.00021	0.126	CrCbGaD
Morphine—ABCB1—prostate gland—prostate cancer	0.000202	0.0115	CbGeAlD
Morphine—CYP3A4—renal system—prostate cancer	0.000195	0.0111	CbGeAlD
Morphine—CYP2D6—renal system—prostate cancer	0.000192	0.0109	CbGeAlD
Morphine—CYP2C8—testis—prostate cancer	0.000186	0.0106	CbGeAlD
Morphine—Codeine—SLC22A1—prostate cancer	0.000183	0.11	CrCbGaD
Morphine—ABCB1—seminal vesicle—prostate cancer	0.000171	0.00972	CbGeAlD
Morphine—ABCB1—epithelium—prostate cancer	0.000149	0.00845	CbGeAlD
Morphine—Codeine—CYP3A5—prostate cancer	0.000148	0.0886	CrCbGaD
Morphine—ABCB1—renal system—prostate cancer	0.000138	0.00783	CbGeAlD
Morphine—ABCB1—urethra—prostate cancer	0.000135	0.0077	CbGeAlD
Morphine—CYP2D6—testis—prostate cancer	0.000124	0.00704	CbGeAlD
Morphine—Naloxone—ESR1—prostate cancer	0.00012	0.0721	CrCbGaD
Morphine—ABCB1—bone marrow—prostate cancer	0.000104	0.00592	CbGeAlD
Morphine—Dihydrocodeine—CYP3A4—prostate cancer	9.57e-05	0.0575	CrCbGaD
Morphine—ABCB1—testis—prostate cancer	8.91e-05	0.00506	CbGeAlD
Morphine—Oxymorphone—CYP3A4—prostate cancer	8.4e-05	0.0504	CrCbGaD
Morphine—Ethylmorphine—CYP3A4—prostate cancer	8.02e-05	0.0482	CrCbGaD
Morphine—Hydrocodone—CYP3A4—prostate cancer	7.34e-05	0.0441	CrCbGaD
Morphine—ABCB1—lymph node—prostate cancer	6.46e-05	0.00367	CbGeAlD
Morphine—Codeine—CYP3A4—prostate cancer	6.39e-05	0.0384	CrCbGaD
Morphine—Naloxone—CYP3A4—prostate cancer	6.12e-05	0.0368	CrCbGaD
Morphine—Hydromorphone—CYP3A4—prostate cancer	6.08e-05	0.0365	CrCbGaD
Morphine—Galantamine—CYP3A4—prostate cancer	5.8e-05	0.0348	CrCbGaD
Morphine—Dermatitis—Mitoxantrone—prostate cancer	1.94e-05	0.00019	CcSEcCtD
Morphine—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.94e-05	0.00019	CcSEcCtD
Morphine—Headache—Mitoxantrone—prostate cancer	1.93e-05	0.000189	CcSEcCtD
Morphine—Hypotension—Capecitabine—prostate cancer	1.93e-05	0.000188	CcSEcCtD
Morphine—Insomnia—Docetaxel—prostate cancer	1.92e-05	0.000188	CcSEcCtD
Morphine—Arthralgia—Prednisone—prostate cancer	1.91e-05	0.000187	CcSEcCtD
Morphine—Paraesthesia—Docetaxel—prostate cancer	1.91e-05	0.000187	CcSEcCtD
Morphine—Anxiety—Prednisone—prostate cancer	1.91e-05	0.000187	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—prostate cancer	1.9e-05	0.000186	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.9e-05	0.000186	CcSEcCtD
Morphine—Dyspnoea—Docetaxel—prostate cancer	1.9e-05	0.000186	CcSEcCtD
Morphine—Somnolence—Docetaxel—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Morphine—Discomfort—Prednisone—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Morphine—Eye disorder—Epirubicin—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Morphine—Hypersensitivity—Etoposide—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Morphine—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.88e-05	0.000184	CcSEcCtD
Morphine—Flushing—Epirubicin—prostate cancer	1.88e-05	0.000184	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—prostate cancer	1.87e-05	0.000183	CcSEcCtD
Morphine—Dyspepsia—Docetaxel—prostate cancer	1.87e-05	0.000183	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—prostate cancer	1.87e-05	0.000183	CcSEcCtD
Morphine—Insomnia—Capecitabine—prostate cancer	1.86e-05	0.000182	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—prostate cancer	1.86e-05	0.000182	CcSEcCtD
Morphine—Paraesthesia—Capecitabine—prostate cancer	1.85e-05	0.000181	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—prostate cancer	1.85e-05	0.000181	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—prostate cancer	1.85e-05	0.000181	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Asthenia—Etoposide—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Dyspnoea—Capecitabine—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Oedema—Prednisone—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Anaphylactic shock—Prednisone—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Morphine—Fatigue—Docetaxel—prostate cancer	1.83e-05	0.00018	CcSEcCtD
Morphine—Angiopathy—Epirubicin—prostate cancer	1.83e-05	0.000179	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—prostate cancer	1.83e-05	0.000179	CcSEcCtD
Morphine—Nausea—Mitoxantrone—prostate cancer	1.83e-05	0.000179	CcSEcCtD
Morphine—Infection—Prednisone—prostate cancer	1.82e-05	0.000178	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—prostate cancer	1.82e-05	0.000178	CcSEcCtD
Morphine—Constipation—Docetaxel—prostate cancer	1.82e-05	0.000178	CcSEcCtD
Morphine—Pain—Docetaxel—prostate cancer	1.82e-05	0.000178	CcSEcCtD
Morphine—Dyspepsia—Capecitabine—prostate cancer	1.81e-05	0.000177	CcSEcCtD
Morphine—Chills—Epirubicin—prostate cancer	1.81e-05	0.000177	CcSEcCtD
Morphine—Pruritus—Etoposide—prostate cancer	1.81e-05	0.000177	CcSEcCtD
Morphine—Shock—Prednisone—prostate cancer	1.81e-05	0.000177	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—prostate cancer	1.8e-05	0.000176	CcSEcCtD
Morphine—Nervous system disorder—Prednisone—prostate cancer	1.8e-05	0.000176	CcSEcCtD
Morphine—Tachycardia—Prednisone—prostate cancer	1.79e-05	0.000175	CcSEcCtD
Morphine—Decreased appetite—Capecitabine—prostate cancer	1.79e-05	0.000175	CcSEcCtD
Morphine—Skin disorder—Prednisone—prostate cancer	1.78e-05	0.000174	CcSEcCtD
Morphine—Gastrointestinal disorder—Capecitabine—prostate cancer	1.78e-05	0.000174	CcSEcCtD
Morphine—Fatigue—Capecitabine—prostate cancer	1.78e-05	0.000174	CcSEcCtD
Morphine—Hyperhidrosis—Prednisone—prostate cancer	1.77e-05	0.000174	CcSEcCtD
Morphine—Mental disorder—Epirubicin—prostate cancer	1.77e-05	0.000173	CcSEcCtD
Morphine—Pain—Capecitabine—prostate cancer	1.76e-05	0.000172	CcSEcCtD
Morphine—Constipation—Capecitabine—prostate cancer	1.76e-05	0.000172	CcSEcCtD
Morphine—Erythema—Epirubicin—prostate cancer	1.76e-05	0.000172	CcSEcCtD
Morphine—Malnutrition—Epirubicin—prostate cancer	1.76e-05	0.000172	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—prostate cancer	1.75e-05	0.000172	CcSEcCtD
Morphine—Diarrhoea—Etoposide—prostate cancer	1.75e-05	0.000171	CcSEcCtD
Morphine—Anorexia—Prednisone—prostate cancer	1.75e-05	0.000171	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—prostate cancer	1.75e-05	0.000171	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—prostate cancer	1.74e-05	0.00017	CcSEcCtD
Morphine—Flushing—Doxorubicin—prostate cancer	1.73e-05	0.00017	CcSEcCtD
Morphine—Flatulence—Epirubicin—prostate cancer	1.73e-05	0.00017	CcSEcCtD
Morphine—Tension—Epirubicin—prostate cancer	1.73e-05	0.000169	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—prostate cancer	1.72e-05	0.000169	CcSEcCtD
Morphine—Nervousness—Epirubicin—prostate cancer	1.71e-05	0.000167	CcSEcCtD
Morphine—Back pain—Epirubicin—prostate cancer	1.7e-05	0.000166	CcSEcCtD
Morphine—Feeling abnormal—Capecitabine—prostate cancer	1.7e-05	0.000166	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—prostate cancer	1.7e-05	0.000166	CcSEcCtD
Morphine—Dizziness—Etoposide—prostate cancer	1.69e-05	0.000166	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—prostate cancer	1.69e-05	0.000165	CcSEcCtD
Morphine—Gastrointestinal pain—Capecitabine—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Morphine—Chills—Doxorubicin—prostate cancer	1.68e-05	0.000164	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.67e-05	0.000164	CcSEcCtD
Morphine—Insomnia—Prednisone—prostate cancer	1.66e-05	0.000162	CcSEcCtD
Morphine—Vision blurred—Epirubicin—prostate cancer	1.66e-05	0.000162	CcSEcCtD
Morphine—Paraesthesia—Prednisone—prostate cancer	1.65e-05	0.000161	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—prostate cancer	1.64e-05	0.00016	CcSEcCtD
Morphine—Urticaria—Capecitabine—prostate cancer	1.64e-05	0.00016	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—prostate cancer	1.63e-05	0.00016	CcSEcCtD
Morphine—Abdominal pain—Capecitabine—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Body temperature increased—Capecitabine—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Vomiting—Etoposide—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Erythema—Doxorubicin—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Anaemia—Epirubicin—prostate cancer	1.63e-05	0.000159	CcSEcCtD
Morphine—Agitation—Epirubicin—prostate cancer	1.62e-05	0.000158	CcSEcCtD
Morphine—Dyspepsia—Prednisone—prostate cancer	1.62e-05	0.000158	CcSEcCtD
Morphine—Rash—Etoposide—prostate cancer	1.61e-05	0.000158	CcSEcCtD
Morphine—Dermatitis—Etoposide—prostate cancer	1.61e-05	0.000158	CcSEcCtD
Morphine—Headache—Etoposide—prostate cancer	1.6e-05	0.000157	CcSEcCtD
Morphine—Flatulence—Doxorubicin—prostate cancer	1.6e-05	0.000157	CcSEcCtD
Morphine—Tension—Doxorubicin—prostate cancer	1.6e-05	0.000156	CcSEcCtD
Morphine—Decreased appetite—Prednisone—prostate cancer	1.6e-05	0.000156	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—prostate cancer	1.59e-05	0.000156	CcSEcCtD
Morphine—Malaise—Epirubicin—prostate cancer	1.59e-05	0.000155	CcSEcCtD
Morphine—Fatigue—Prednisone—prostate cancer	1.58e-05	0.000155	CcSEcCtD
Morphine—Nervousness—Doxorubicin—prostate cancer	1.58e-05	0.000155	CcSEcCtD
Morphine—Vertigo—Epirubicin—prostate cancer	1.58e-05	0.000155	CcSEcCtD
Morphine—Syncope—Epirubicin—prostate cancer	1.58e-05	0.000154	CcSEcCtD
Morphine—Leukopenia—Epirubicin—prostate cancer	1.57e-05	0.000154	CcSEcCtD
Morphine—Back pain—Doxorubicin—prostate cancer	1.57e-05	0.000154	CcSEcCtD
Morphine—Constipation—Prednisone—prostate cancer	1.57e-05	0.000154	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—prostate cancer	1.57e-05	0.000153	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—prostate cancer	1.56e-05	0.000153	CcSEcCtD
Morphine—Palpitations—Epirubicin—prostate cancer	1.55e-05	0.000152	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—prostate cancer	1.55e-05	0.000151	CcSEcCtD
Morphine—Cough—Epirubicin—prostate cancer	1.53e-05	0.00015	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—prostate cancer	1.53e-05	0.00015	CcSEcCtD
Morphine—Asthenia—Docetaxel—prostate cancer	1.53e-05	0.000149	CcSEcCtD
Morphine—Convulsion—Epirubicin—prostate cancer	1.52e-05	0.000149	CcSEcCtD
Morphine—Nausea—Etoposide—prostate cancer	1.52e-05	0.000149	CcSEcCtD
Morphine—Hypertension—Epirubicin—prostate cancer	1.52e-05	0.000149	CcSEcCtD
Morphine—Hypersensitivity—Capecitabine—prostate cancer	1.52e-05	0.000149	CcSEcCtD
Morphine—Feeling abnormal—Prednisone—prostate cancer	1.51e-05	0.000148	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—prostate cancer	1.51e-05	0.000148	CcSEcCtD
Morphine—Pruritus—Docetaxel—prostate cancer	1.51e-05	0.000147	CcSEcCtD
Morphine—Anaemia—Doxorubicin—prostate cancer	1.5e-05	0.000147	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—prostate cancer	1.5e-05	0.000147	CcSEcCtD
Morphine—Chest pain—Epirubicin—prostate cancer	1.5e-05	0.000147	CcSEcCtD
Morphine—Arthralgia—Epirubicin—prostate cancer	1.5e-05	0.000147	CcSEcCtD
Morphine—Agitation—Doxorubicin—prostate cancer	1.5e-05	0.000146	CcSEcCtD
Morphine—Anxiety—Epirubicin—prostate cancer	1.49e-05	0.000146	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.49e-05	0.000146	CcSEcCtD
Morphine—Discomfort—Epirubicin—prostate cancer	1.48e-05	0.000145	CcSEcCtD
Morphine—Asthenia—Capecitabine—prostate cancer	1.48e-05	0.000145	CcSEcCtD
Morphine—Malaise—Doxorubicin—prostate cancer	1.47e-05	0.000144	CcSEcCtD
Morphine—Dry mouth—Epirubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Vertigo—Doxorubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Syncope—Doxorubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Urticaria—Prednisone—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Pruritus—Capecitabine—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—prostate cancer	1.46e-05	0.000142	CcSEcCtD
Morphine—Body temperature increased—Prednisone—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Morphine—Abdominal pain—Prednisone—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Morphine—Confusional state—Epirubicin—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Morphine—Palpitations—Doxorubicin—prostate cancer	1.44e-05	0.000141	CcSEcCtD
Morphine—Oedema—Epirubicin—prostate cancer	1.44e-05	0.00014	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—prostate cancer	1.44e-05	0.00014	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—prostate cancer	1.43e-05	0.00014	CcSEcCtD
Morphine—Infection—Epirubicin—prostate cancer	1.43e-05	0.00014	CcSEcCtD
Morphine—Cough—Doxorubicin—prostate cancer	1.42e-05	0.000139	CcSEcCtD
Morphine—Shock—Epirubicin—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Convulsion—Doxorubicin—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Diarrhoea—Capecitabine—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Dizziness—Docetaxel—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—prostate cancer	1.41e-05	0.000138	CcSEcCtD
Morphine—Hypertension—Doxorubicin—prostate cancer	1.41e-05	0.000137	CcSEcCtD
Morphine—Tachycardia—Epirubicin—prostate cancer	1.4e-05	0.000137	CcSEcCtD
Morphine—Skin disorder—Epirubicin—prostate cancer	1.39e-05	0.000136	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—prostate cancer	1.39e-05	0.000136	CcSEcCtD
Morphine—Chest pain—Doxorubicin—prostate cancer	1.39e-05	0.000136	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—prostate cancer	1.39e-05	0.000136	CcSEcCtD
Morphine—Anxiety—Doxorubicin—prostate cancer	1.38e-05	0.000135	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.38e-05	0.000135	CcSEcCtD
Morphine—Discomfort—Doxorubicin—prostate cancer	1.37e-05	0.000134	CcSEcCtD
Morphine—Anorexia—Epirubicin—prostate cancer	1.37e-05	0.000134	CcSEcCtD
Morphine—Dizziness—Capecitabine—prostate cancer	1.36e-05	0.000133	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—prostate cancer	1.35e-05	0.000133	CcSEcCtD
Morphine—Vomiting—Docetaxel—prostate cancer	1.35e-05	0.000132	CcSEcCtD
Morphine—Hypersensitivity—Prednisone—prostate cancer	1.35e-05	0.000132	CcSEcCtD
Morphine—Rash—Docetaxel—prostate cancer	1.34e-05	0.000131	CcSEcCtD
Morphine—Hypotension—Epirubicin—prostate cancer	1.34e-05	0.000131	CcSEcCtD
Morphine—Dermatitis—Docetaxel—prostate cancer	1.34e-05	0.000131	CcSEcCtD
Morphine—Confusional state—Doxorubicin—prostate cancer	1.34e-05	0.000131	CcSEcCtD
Morphine—Headache—Docetaxel—prostate cancer	1.33e-05	0.00013	CcSEcCtD
Morphine—Oedema—Doxorubicin—prostate cancer	1.33e-05	0.00013	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—prostate cancer	1.33e-05	0.00013	CcSEcCtD
Morphine—Infection—Doxorubicin—prostate cancer	1.32e-05	0.000129	CcSEcCtD
Morphine—Asthenia—Prednisone—prostate cancer	1.32e-05	0.000129	CcSEcCtD
Morphine—Vomiting—Capecitabine—prostate cancer	1.31e-05	0.000128	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.31e-05	0.000128	CcSEcCtD
Morphine—Shock—Doxorubicin—prostate cancer	1.31e-05	0.000128	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Rash—Capecitabine—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Pruritus—Prednisone—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Insomnia—Epirubicin—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Dermatitis—Capecitabine—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Morphine—Headache—Capecitabine—prostate cancer	1.29e-05	0.000126	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—prostate cancer	1.29e-05	0.000126	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—prostate cancer	1.29e-05	0.000126	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—prostate cancer	1.28e-05	0.000126	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—prostate cancer	1.28e-05	0.000125	CcSEcCtD
Morphine—Somnolence—Epirubicin—prostate cancer	1.28e-05	0.000125	CcSEcCtD
Morphine—Anorexia—Doxorubicin—prostate cancer	1.27e-05	0.000124	CcSEcCtD
Morphine—Nausea—Docetaxel—prostate cancer	1.26e-05	0.000124	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—prostate cancer	1.26e-05	0.000124	CcSEcCtD
Morphine—Diarrhoea—Prednisone—prostate cancer	1.26e-05	0.000123	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—prostate cancer	1.25e-05	0.000122	CcSEcCtD
Morphine—Hypotension—Doxorubicin—prostate cancer	1.24e-05	0.000121	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.24e-05	0.000121	CcSEcCtD
Morphine—Fatigue—Epirubicin—prostate cancer	1.24e-05	0.000121	CcSEcCtD
Morphine—Constipation—Epirubicin—prostate cancer	1.23e-05	0.00012	CcSEcCtD
Morphine—Pain—Epirubicin—prostate cancer	1.23e-05	0.00012	CcSEcCtD
Morphine—Nausea—Capecitabine—prostate cancer	1.22e-05	0.00012	CcSEcCtD
Morphine—Dizziness—Prednisone—prostate cancer	1.21e-05	0.000119	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.21e-05	0.000118	CcSEcCtD
Morphine—Insomnia—Doxorubicin—prostate cancer	1.2e-05	0.000118	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—prostate cancer	1.19e-05	0.000117	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—prostate cancer	1.18e-05	0.000116	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—prostate cancer	1.18e-05	0.000116	CcSEcCtD
Morphine—Somnolence—Doxorubicin—prostate cancer	1.18e-05	0.000116	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—prostate cancer	1.17e-05	0.000115	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—prostate cancer	1.17e-05	0.000114	CcSEcCtD
Morphine—Vomiting—Prednisone—prostate cancer	1.17e-05	0.000114	CcSEcCtD
Morphine—Rash—Prednisone—prostate cancer	1.16e-05	0.000113	CcSEcCtD
Morphine—Dermatitis—Prednisone—prostate cancer	1.16e-05	0.000113	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Morphine—Headache—Prednisone—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.15e-05	0.000112	CcSEcCtD
Morphine—Fatigue—Doxorubicin—prostate cancer	1.15e-05	0.000112	CcSEcCtD
Morphine—Urticaria—Epirubicin—prostate cancer	1.14e-05	0.000112	CcSEcCtD
Morphine—Constipation—Doxorubicin—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Morphine—Pain—Doxorubicin—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Morphine—Nausea—Prednisone—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.09e-05	0.000106	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—prostate cancer	1.06e-05	0.000103	CcSEcCtD
Morphine—Urticaria—Doxorubicin—prostate cancer	1.06e-05	0.000103	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Morphine—Asthenia—Epirubicin—prostate cancer	1.03e-05	0.000101	CcSEcCtD
Morphine—Pruritus—Epirubicin—prostate cancer	1.02e-05	9.94e-05	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—prostate cancer	9.82e-06	9.61e-05	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—prostate cancer	9.79e-06	9.58e-05	CcSEcCtD
Morphine—Asthenia—Doxorubicin—prostate cancer	9.53e-06	9.33e-05	CcSEcCtD
Morphine—Dizziness—Epirubicin—prostate cancer	9.49e-06	9.29e-05	CcSEcCtD
Morphine—Pruritus—Doxorubicin—prostate cancer	9.4e-06	9.2e-05	CcSEcCtD
Morphine—Vomiting—Epirubicin—prostate cancer	9.13e-06	8.93e-05	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—prostate cancer	9.09e-06	8.89e-05	CcSEcCtD
Morphine—Rash—Epirubicin—prostate cancer	9.05e-06	8.86e-05	CcSEcCtD
Morphine—Dermatitis—Epirubicin—prostate cancer	9.04e-06	8.85e-05	CcSEcCtD
Morphine—Headache—Epirubicin—prostate cancer	8.99e-06	8.8e-05	CcSEcCtD
Morphine—Dizziness—Doxorubicin—prostate cancer	8.78e-06	8.59e-05	CcSEcCtD
Morphine—Nausea—Epirubicin—prostate cancer	8.53e-06	8.34e-05	CcSEcCtD
Morphine—Vomiting—Doxorubicin—prostate cancer	8.44e-06	8.26e-05	CcSEcCtD
Morphine—Rash—Doxorubicin—prostate cancer	8.37e-06	8.2e-05	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—prostate cancer	8.37e-06	8.19e-05	CcSEcCtD
Morphine—Headache—Doxorubicin—prostate cancer	8.32e-06	8.14e-05	CcSEcCtD
Morphine—Nausea—Doxorubicin—prostate cancer	7.89e-06	7.72e-05	CcSEcCtD
Morphine—OPRM1—Signaling Pathways—IRS1—prostate cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTA2—prostate cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NQO1—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RXRA—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOS3—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCG5—prostate cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TH—prostate cancer	1.18e-06	1.34e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP3A4—prostate cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GSK3B—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JAK2—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTA1—prostate cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—COMT—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INS—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1B1—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAT2—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTO1—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—prostate cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—prostate cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NQO1—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ITPR1—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CREBBP—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—prostate cancer	1.11e-06	1.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	1.11e-06	1.27e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TH—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GGT1—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—prostate cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLCB2—prostate cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LRP2—prostate cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOA1—prostate cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—prostate cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	1.08e-06	1.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—prostate cancer	1.08e-06	1.23e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.08e-06	1.23e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP19A1—prostate cancer	1.08e-06	1.23e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—P4HB—prostate cancer	1.07e-06	1.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	1.07e-06	1.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—prostate cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—prostate cancer	1.06e-06	1.2e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GGT1—prostate cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—prostate cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RXRA—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—prostate cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LPL—prostate cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGF2—prostate cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—prostate cancer	1.01e-06	1.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—prostate cancer	1.01e-06	1.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—prostate cancer	1e-06	1.15e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MED12—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—COMT—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—prostate cancer	9.95e-07	1.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—prostate cancer	9.95e-07	1.13e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNG5—prostate cancer	9.93e-07	1.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ERCC2—prostate cancer	9.87e-07	1.13e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—prostate cancer	9.83e-07	1.12e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—prostate cancer	9.8e-07	1.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ITPR1—prostate cancer	9.79e-07	1.12e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RXRA—prostate cancer	9.78e-07	1.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—prostate cancer	9.77e-07	1.11e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JAK2—prostate cancer	9.77e-07	1.11e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	9.73e-07	1.11e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—prostate cancer	9.67e-07	1.1e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	9.57e-07	1.09e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA3—prostate cancer	9.56e-07	1.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—prostate cancer	9.54e-07	1.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—prostate cancer	9.53e-07	1.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	9.51e-07	1.08e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—prostate cancer	9.48e-07	1.08e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—COMT—prostate cancer	9.42e-07	1.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	9.4e-07	1.07e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—prostate cancer	9.38e-07	1.07e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—prostate cancer	9.35e-07	1.07e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—prostate cancer	9.28e-07	1.06e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	9.28e-07	1.06e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—prostate cancer	9.25e-07	1.06e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—prostate cancer	9.25e-07	1.05e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ITPR1—prostate cancer	9.23e-07	1.05e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—prostate cancer	9.15e-07	1.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HPGDS—prostate cancer	9.12e-07	1.04e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARA—prostate cancer	9.1e-07	1.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2C19—prostate cancer	9.06e-07	1.03e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—prostate cancer	9.05e-07	1.03e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—prostate cancer	8.99e-07	1.02e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LPL—prostate cancer	8.98e-07	1.02e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—prostate cancer	8.97e-07	1.02e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	8.91e-07	1.02e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—prostate cancer	8.85e-07	1.01e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ACHE—prostate cancer	8.85e-07	1.01e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—prostate cancer	8.8e-07	1e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—prostate cancer	8.79e-07	1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.75e-07	9.97e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—prostate cancer	8.72e-07	9.94e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	8.71e-07	9.93e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—prostate cancer	8.67e-07	9.89e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—prostate cancer	8.62e-07	9.83e-06	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	8.61e-07	9.82e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ERCC2—prostate cancer	8.6e-07	9.81e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—prostate cancer	8.57e-07	9.77e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAV1—prostate cancer	8.56e-07	9.76e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—prostate cancer	8.53e-07	9.73e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—prostate cancer	8.52e-07	9.71e-06	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—prostate cancer	8.51e-07	9.7e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C3—prostate cancer	8.51e-07	9.7e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—prostate cancer	8.48e-07	9.67e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—prostate cancer	8.48e-07	9.66e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PRKACB—prostate cancer	8.46e-07	9.65e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LPL—prostate cancer	8.46e-07	9.65e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP17A1—prostate cancer	8.38e-07	9.55e-06	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—prostate cancer	8.31e-07	9.47e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—prostate cancer	8.31e-07	9.47e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	8.22e-07	9.38e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.18e-07	9.32e-06	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—prostate cancer	8.18e-07	9.32e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—prostate cancer	8.17e-07	9.32e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ERCC2—prostate cancer	8.1e-07	9.24e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—prostate cancer	8.08e-07	9.22e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—prostate cancer	8.06e-07	9.19e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	8.03e-07	9.16e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—prostate cancer	8.02e-07	9.14e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA2—prostate cancer	7.98e-07	9.1e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARA—prostate cancer	7.93e-07	9.04e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—prostate cancer	7.88e-07	8.99e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—prostate cancer	7.86e-07	8.96e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	7.82e-07	8.92e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—prostate cancer	7.8e-07	8.89e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—prostate cancer	7.71e-07	8.79e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—prostate cancer	7.64e-07	8.72e-06	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	7.63e-07	8.7e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—prostate cancer	7.62e-07	8.69e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.61e-07	8.68e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARA—prostate cancer	7.47e-07	8.52e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAV1—prostate cancer	7.46e-07	8.5e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2E1—prostate cancer	7.44e-07	8.48e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—prostate cancer	7.43e-07	8.48e-06	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—prostate cancer	7.38e-07	8.42e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—INS—prostate cancer	7.38e-07	8.41e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NQO1—prostate cancer	7.35e-07	8.38e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—prostate cancer	7.28e-07	8.3e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TH—prostate cancer	7.25e-07	8.26e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	7.24e-07	8.25e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CREBBP—prostate cancer	7.23e-07	8.24e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—prostate cancer	7.17e-07	8.17e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1B1—prostate cancer	7.05e-07	8.04e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAV1—prostate cancer	7.03e-07	8.01e-06	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—prostate cancer	6.95e-07	7.93e-06	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—prostate cancer	6.92e-07	7.89e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—prostate cancer	6.85e-07	7.81e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GGT1—prostate cancer	6.83e-07	7.78e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—prostate cancer	6.79e-07	7.74e-06	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—prostate cancer	6.76e-07	7.7e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA1—prostate cancer	6.73e-07	7.67e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	6.69e-07	7.63e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—prostate cancer	6.66e-07	7.6e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	6.65e-07	7.58e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.63e-07	7.56e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—prostate cancer	6.52e-07	7.43e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—prostate cancer	6.47e-07	7.38e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—prostate cancer	6.47e-07	7.38e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—INS—prostate cancer	6.43e-07	7.33e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—prostate cancer	6.4e-07	7.3e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RXRA—prostate cancer	6.4e-07	7.29e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CREBBP—prostate cancer	6.3e-07	7.18e-06	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—prostate cancer	6.23e-07	7.11e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—COMT—prostate cancer	6.16e-07	7.03e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—prostate cancer	6.16e-07	7.02e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—prostate cancer	6.13e-07	6.99e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—INS—prostate cancer	6.06e-07	6.91e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ITPR1—prostate cancer	6.03e-07	6.88e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.97e-07	6.81e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—prostate cancer	5.97e-07	6.81e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CREBBP—prostate cancer	5.93e-07	6.77e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—prostate cancer	5.93e-07	6.76e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—prostate cancer	5.92e-07	6.75e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—prostate cancer	5.7e-07	6.5e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	5.66e-07	6.45e-06	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—prostate cancer	5.65e-07	6.44e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—prostate cancer	5.64e-07	6.43e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—prostate cancer	5.64e-07	6.43e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.63e-07	6.42e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPL—prostate cancer	5.53e-07	6.31e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—prostate cancer	5.47e-07	6.24e-06	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—prostate cancer	5.47e-07	6.23e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.34e-07	6.09e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—prostate cancer	5.31e-07	6.06e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ERCC2—prostate cancer	5.3e-07	6.04e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—prostate cancer	5.2e-07	5.93e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—prostate cancer	5.16e-07	5.89e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—prostate cancer	5.16e-07	5.88e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—prostate cancer	5.01e-07	5.71e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.98e-07	5.68e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—prostate cancer	4.92e-07	5.61e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.9e-07	5.59e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARA—prostate cancer	4.89e-07	5.57e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—prostate cancer	4.86e-07	5.54e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—prostate cancer	4.62e-07	5.27e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAV1—prostate cancer	4.59e-07	5.24e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—prostate cancer	4.5e-07	5.13e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—prostate cancer	4.29e-07	4.89e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—prostate cancer	4.24e-07	4.83e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.18e-07	4.77e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—prostate cancer	4.04e-07	4.61e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—INS—prostate cancer	3.96e-07	4.52e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.88e-07	4.42e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.68e-07	4.19e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.64e-07	4.15e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—prostate cancer	3.47e-07	3.96e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.21e-07	3.66e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.18e-07	3.62e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.17e-07	3.62e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.99e-07	3.41e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—prostate cancer	2.97e-07	3.39e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—prostate cancer	2.77e-07	3.16e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—prostate cancer	2.64e-07	3.01e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—prostate cancer	2.59e-07	2.96e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—prostate cancer	2.44e-07	2.78e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.95e-07	2.23e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—prostate cancer	1.6e-07	1.82e-06	CbGpPWpGaD
